Abstract Objective Vaginal cancer is an uncommon cancer of the lower genital tract, and standardized screening is not recommended. Risk factors for vaginal cancer include a history of other lower genital tract neoplasia or cancer, smoking, immunosuppression, and exposure to diethylstilbestrol in utero. Our objective is to review the literature on vaginal cytology and hrHPV testing and to develop guidance for the management of abnormal vaginal screening tests. Methods An electronic search of the PubMed database through was performed. Articles describing vaginal cytology or vaginal hrHPV testing were reviewed, and diagnostic accuracy of these tests when available was noted. Results The available literature was too limited to develop evidence-based recommendations for managing abnormal vaginal cytology and hrHPV screening tests.

Author:Groshicage JoJojin
Language:English (Spanish)
Published (Last):15 January 2006
PDF File Size:11.68 Mb
ePub File Size:20.53 Mb
Price:Free* [*Free Regsitration Required]

A survey of program directors in obstetrics and gynecology and family practices. Data is limited on how the continually changing guidelines have affected colposcopy procedure numbers in Obstetrics and Gynecology residency training programs.

Cervical cytology should be performed every three years in women 21 to 29 years of age. Cervix Uteri Cancer [updated June 28] Guudelines from: The Accreditation Council for Graduate Medical Education ACGME does not require residency training programs to report the number of colposcopies residents perform during their training, though they track statistics on other types of office-based procedures.

Inthe cervical cancer incidence in the United States was 7. Seventy-three colposcopies were performed during the one-year study period, April 1, to March 31,prior to the release of the ASCCP guidelines. The American Society for Colposcopy and Cervical Pathology guideline should be followed for all other scenarios. The ASCCP guidelines recommended longer screening intervals, later initiation of screening, increased use of HPV co-testing for evaluation of mild abnormalities, and an overall reduction in colposcopy in instances where the risk of cervical cancer is low.

Guidelines — ASCCP Screening should begin at 21 years of age, regardless of age at sexual initiation or other behavior-related risk factors.

These results were then compared to the actual number of colposcopies performed between April 1, and March 31, as well as the actual number of colposcopies performed between April 1, and March 31,the one-year time frame after the release of the guidelines. This data was collected from a single resident clinic and does not include resident colposcopy experience gained outside of this particular clinic such as continuity clinics or gynecologic oncology clinics.

The secondary objective was to determine the actual number of colposcopies before and after the ASCCP guidelines. American College of Obstetricians and Gynecologists Evidence rating system used? We projected a large proportion of the decline would be in women age 21 to 24 in whom low grade cytologic abnormalities were no longer an indication for colposcopy. Though our results are reflective of current trends that we predict are affecting training programs in the U.

A challenge with cotesting is the counseling and treatment of women 30 years and older with negative results on cytology but positive results on HPV testing. J Low Genit Tract Dis. Both liquid-based and conventional methods of cervical cytology are acceptable. Examples of updates include: Applies to women without a cervix and without a history of CIN 2, CIN 3, adenocarcinoma in situ, or cancer in the past 20 years. Conflict of Interest None of the authors identify any conflict of interest.

The incidence of cervical cancer, as well as mortality rates from the disease, has decreased over the past 30 years because of widespread screening with cervical cytology. Guidelnies compared worldwide, cervical cancer in the United States has a relatively low incidence. To see the full article, log in or purchase access. Both the predicted and actual colposcopy numbers demonstrated that the decrease in procedures was more evident in patients with low-grade cytologic abnormalities than high-grade abnormalities.

Our study suggests residents will get less training in evaluating mild abnormalities while getting a similar experience in evaluating high-grade abnormalities. Women 30 to 65 years of age.

Otherwise, the patient should receive routine screening. After applying the ASCCP guidelines, 35 of 73 colposcopies would still be performed and 38 would no longer be indicated, resulting in a There are no studies regarding screening in women who are otherwise immunocompromised; however, annual cytology starting at 21 years of age is reasonable.

Want to use this article elsewhere? Guidelines Those who have cytology results showing atypical squamous cells of undetermined significance should receive HPV testing. Thus, exact procedure numbers that arise from this specialty colposcopy clinic do not reflect the entire colposcopic experience obtained by the residents in our program.

National, regional, state, and selected local area vaccination coverage among adolescents aged 13—17 year — United States, The first part applied the ASCCP guidelines to all pre-guideline colposcopy cases at a single resident clinic. Continue reading from December 1, Previous: The second part compared the actual number of colposcopies during the one-year time period before and after the guidelines. Because cervical cancer usually occurs 15 to 25 years after HPV infection, screening women older than 65 years would prevent few cases of cancer.

Fifty-eight indicated colposcopies were actually performed during the post-guideline period. A study from a Family Medicine program found an actual Ultimately, patients benefited from a reduced number of invasive procedures. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.

These theoretical results were then compared to the actual number of colposcopies. Patients screened with cytology alone who have negative results should receive cytology screening again in three years. Cytology alone acceptable every three years. United States Cancer Statistics: In particular, residents will have less experience evaluating low grade cytologic abnormalities in younger women. Cervical cancer screening guidelines have changed dramatically over the last 10 years with a trend towards decreasing the frequency of screening in more restricted age groups age 21 to Related Articles.



From a medical education standpoint, if there is no change to the current training methods, there is a risk that residents may not get adequate training to achieve competency. Patients 24 years and younger 3. We hypothesize the decreased number of young patients requiring colposcopy left more clinic appointments open for outside referrals which tended assccp represent an older demographic population. Residency programs should evaluate their colposcopy training curriculum in light of the guideline aasccp.








Related Articles